284 related articles for article (PubMed ID: 17589924)
21. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
22. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
[TBL] [Abstract][Full Text] [Related]
24. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.
Schillie SF; Murphy TV
Vaccine; 2013 May; 31(21):2506-16. PubMed ID: 23257713
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women.
Ko SC; Schillie SF; Walker T; Veselsky SL; Nelson NP; Lazaroff J; Crowley S; Dusek C; Loggins K; Onye K; Fenlon N; Murphy TV
Vaccine; 2014 Apr; 32(18):2127-33. PubMed ID: 24560676
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of indigenous recombinant hepatitis B vaccine (Shanvac-B) in comparison with commercially available vaccine.
Joshi N; Kumar A; Sreenivas DV; Palan S; Nagarjuna Kumar YR
Indian J Gastroenterol; 2000; 19(2):71-3. PubMed ID: 10812819
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
[TBL] [Abstract][Full Text] [Related]
30. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
32. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
Martins RM; Bensabath G; Arraes LC; Oliveira Mde L; Miguel JC; Barbosa GG; Camacho LA
Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):865-71. PubMed ID: 15761604
[TBL] [Abstract][Full Text] [Related]
33. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
Euler GL; Copeland JR; Rangel MC; Williams WW
Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
35. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
[TBL] [Abstract][Full Text] [Related]
36. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital.
Thomas RJ; Fletcher GJ; Kirupakaran H; Chacko MP; Thenmozhi S; Eapen CE; Chandy G; Abraham P
Indian J Med Microbiol; 2015 Feb; 33 Suppl():32-6. PubMed ID: 25657153
[TBL] [Abstract][Full Text] [Related]
38. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
39. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
